Alio receives second FDA Clearance
Alio receives second FDA Clearance dschroeder19
Company secures second FDA clearance for its remote patient monitoring platform, adding three new
FDA Clears Viz.ai\'s AI Algorithm for Abdominal Aortic Aneurysm
FDA Clears Viz.ai\'s AI Algorithm for Abdominal Aortic Aneurysm sbrusco@rodmanmedia.com (Sam Brusco)
Viz.ai has
TytoCare receives FDA 510(k) for wheeze detection software
TytoCare receives FDA 510(k) for wheeze detection software unknown
Virtual primary care company TytoCare received FDA 510(k) clearance
Singaporean startup Respiree gets US FDA 510(k) for respiration monitor
Singaporean startup Respiree gets US FDA 510(k) for respiration monitor unknown
Respiree, a med tech spinoff of Singapore'
FDA updates for Week of March 6, 2023
FDA updates for Week of March 6, 2023 unknown
FDA approves novel nasal spray for migraine.
The FDA has approved
Theranica receives FDA 510(k) for migraine prevention device
Theranica receives FDA 510(k) for migraine prevention device unknown
Prescription digital therapeutic developer Theranica announced it had received FDA
The FDA Regulatory Landscape For AI In Medical Devices
The FDA Regulatory Landscape For AI In Medical Devices unknown
By Michele Buenafe, Jake Harper, and Andrew Gray
In recent
FDA Updates for Week of Feb. 27, 2023
FDA Updates for Week of Feb. 27, 2023 unknown
FDA approves Kevzara for inflammatory rheumatic disease.
The FDA has approved
FDA Updates for Week of Feb. 20, 2023
FDA Updates for Week of Feb. 20, 2023 unknown
FDA approves weekly hemophilia A therapy.
The FDA has approved Altuviiio
STAT+: The FDA plans to regulate far more AI tools as devices. The industry won’t go down without a fight
STAT+: The FDA plans to regulate far more AI tools as devices. The industry won’t go down without a